Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Fengli Wen"'
Publikováno v:
Journal of Orthopaedic Surgery, Vol 30 (2022)
Objective Osteoporosis (OP) is a widespread disease that causes risks of spine and hip fractures. Morinda officinalis polysaccharide (MOP) shows therapeutic potential in OP. This article intended to understand the mechanism by which MOP impacts bone
Externí odkaz:
https://doaj.org/article/e8fc0a10c2f44f9190d8b6db15f56aa2
Autor:
Kai Rong, Yi Lang, Yubo Zhou, Liangtao Ni, Lei Wang, Long Wang, Yaowu Zhang, Fengli Wen, Zhan Wang, Pingbo Chen
Publikováno v:
Journal of Inflammation Research.
Kai Rong, Yi Lang, Yubo Zhou, Liangtao Ni, Lei Wang, Long Wang, Yaowu Zhang, Fengli Wen, Zhan Wang, Pingbo Chen Department of Traumatology, Traditional Chinese Medicine Hospital Affiliated to Xinjiang Medical University, Wulumuqi, Xinjiang, Peopleâ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa10e8f065c5cd743b2eb31c50ebcae9
https://www.dovepress.com/risk-genetic-variants-il-10-for-osteoporosis-in-han-population-from-no-peer-reviewed-fulltext-article-JIR
https://www.dovepress.com/risk-genetic-variants-il-10-for-osteoporosis-in-han-population-from-no-peer-reviewed-fulltext-article-JIR
Publikováno v:
International journal of immunogeneticsREFERENCES. 48(6)
AIMS Interleukin 1 (IL-1) inhibitory receptor type 2 (IL1R2) serves as a negative regulator of IL-1 signalling and is involved in the pathogenesis of osteoporosis. This study aimed to determine the correlation between IL1R2 polymorphism and osteoporo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51426049f5e504fe9d19191ddbc3a964
https://pubmed.ncbi.nlm.nih.gov/34664761
https://pubmed.ncbi.nlm.nih.gov/34664761
Background: IL-1R2, serves as a negative regulator of IL-1 signaling, is involved in the pathogenesis of osteoporosis. This study aimed to determine the correlation between IL-1R2 polymorphism and osteoporosis susceptibility among the Chinese Han pop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a328fda31e06387da6772ea2448b3bb
https://doi.org/10.21203/rs.3.rs-25428/v1
https://doi.org/10.21203/rs.3.rs-25428/v1
Publikováno v:
International Journal of Immunogenetics; Dec2021, Vol. 48 Issue 6, p510-525, 16p